Ulcerative Colitis

Ulcerative Colitis


ULCERATIVE COLITIS

 

Limited to colon and rectum

 

HLA-DR2, HLA DR103

 

  • Non-smokers, ex-smokers – higher risk
  • Appendicectomy before 20 years protects against UC

 

Morphology

Continuous lesions

 

Thin bowel wall

 

Rare

 

Limited to mucosa

 

No granulomas

 

Marked number of Pseudopolyps (tips fuse to

form mucosal bridges)

 

Superficial broad-based ulcers

 

Mild to none

 

Absent

 

Rectum always involved

 

  • Rectum always involved and disease extends proximally (pancolitis and backwash ileitis)
  • Crypt abscess

 

Clinical features

Relapsing disorder with attacks of bloody diarrhea

(usually nocturnal/postprandial), cramps, fecal

urgency

 

Infrequent

 

Increased incidence of perforation

 

Absent

 

Malignant potential (UC > CD)

 

Rare

 

Toxic megacolon seen (diameter > 6 cm)

 

Investigations

75% pANCA positive

10% ASCA +ve

 

Barium enema

  • Loss of haustrations
  • Narrow contracted colon (hose pipe colon)
  • Mucosal changes caused by granularity
  • Chronic – narrow contracted colon

 

  • Fecal lactoferrin – marker for intestinal inflammation
  • Fecal calprotectin – correlate with, predict relapses, detect pouchitis

 

Treatment

  • Mild to moderate distal colitis – topical mesalamine is the drug of choice
  • Mild to moderate disease extending above the sigmoid colon
  • Oral 5-ASA agents
  • No response – add prednisone
  • No response- immunomodulators
  • Severe colitis
  • IV Methyiprednisolone
  • No response – Infliximab
  • No response – Cyclosporine
  • No response – Surgery
  • Fulminant colitis & Toxic megacolon not improving in 48-72 hours à surgery–Total proctocolectomy

Exam Question

  • The pathology in ulcerative colitis typically involves distortion of crypt architecture, inflammation of crypts (cryptitis), frank crypt abscess, and hemorrhage or inflammatory cells in the lamina propria.
  • Crohn’s disease is frequently associated with “skip lesions,” discontinuous areas of active disease in the colon and small intestine with intervening segments that appear normal.
  • Pseudopolyps are more commonly found in ulcerative colitis than Crohn’s disease.
  • For patients of ulcerative colitis associated with primary sclerosing cholangitis :They may develop biliary cirrhosis , may have raised alkaline phosphatase ,increased risk of hilar Cholangiocarcinoma.
  • Ulcerative Colitis is associated with:
  • Dermatologic: Erythema nodosum ,Pyoderma gangrenosum
  • Rheumatologic: Peripheral arthritis, Ankylosing spondylitis, Sacroiliitis
  • Ocular:Conjunctivitis ,Anterior uveitis/iritis ,Episcleritis
  • Hepatobiliary: Hepatic steatosis ,Fatty liver ,Cholelithiasi ,Primary sclerosing cholangitis
  • Urologic: Calculi ,Ileal bladder fistulas
  • Metabolic bone disorders
  • Thromboembolic disorders.
  • Ulcerative colitis (UC) is a chronic inflammatory condition causing continuous mucosal inflammation of the colon without granulomas on biopsy, affecting the rectum and a variable extent of the colon in continuity, characterised by relapsing and remitting course.
  • Distal colitis with respect to ulcerative colitis refers to Left sided colon distal to splenic flexure is only involved.
  • Parameters of truelove witts criteria :  Bloody stools/day ,Pulse, Temperature, Haemoglobin, ESR, CRP.
  • In clinical practice, ‘remission’ mean a stool frequency ≤3/day with no bleeding and no urgency. Sigmoidoscopy to confirm mucosal healing is generally unnecessary.
  • Steroid refractory ulcerative colitis is said to be present in a patients who have active disease despite Prednisolone up to 0.75 mg/kg/day over a period of 4 weeks.
  • Baron Endoscopic scores for ulcerative colitis
  • Score 0: Normal: matt mucosa, ramifying vascular pattern clearly visible, no spontaneous bleeding, no bleeding to light touch
  • Score 1: Abnormal, but non-haemorrhagic: appearances between 0 and 2
  • Score 2: Moderately hemorrhagic: bleeding to light touch, but no spontaneous bleeding seen ahead of the instrument on initial inspection
  • Score 3: Severely haemorrhagic: spontaneous bleeding seen ahead of instrument at initial inspection and bleeds to light touch.
  • Occasional severe constipation is seen in ulcerative colitis patients with Proctitis.
  • Pancolitis and Pseudopolyps may be seen in Ulcerative Colitis.
  •  Ulcerative colitis involves the rectum and extends proximally in a retrograde fashion to involve the entire colon (pancolitis) in more severe cases.
  • Malabsorption may be seen in ulcerative colitis.
  • Sulfasalazine is used in ulcerative colitis.
  • Pyoderma gangrenosum is seen in Ulcerative Colitis.
  • Rx of choice in case of chronic ulcerative colitis is Proctocolectomy with Ileo-Anal Anastomosis.
  • Surgical treatment of Ulcerative Colitis :Done in cases where medical treatment fails &  Pouch surgery done.
  • Complications of ulcerative colitis : Perforation  ,Toxic megacolon, Carcinoma.
  • As the inflammation is purely mucosal in ulcerative colitis, strictures are highly uncommon. Any stricture diagnosed in a patient with ulcerative colitis is presumed to be malignant until proven otherwise.
  • Ulcerative colitis involves mucosa and superficial submucosa with deeper layers unaffected except in fulminant disease.
  • Pt with recurrent diarrhoea, pseudopolyp, lead pipe appearance on Ba enema has Ulcerative Colitis.
  • Risk of Malignancy in Ulcerative Colitis is more in :Onset in childhood ; Extensive involvement of colon,Takes atleast 10 years to develop,Associated with dysplasia of the rest of the colon.
  • Primary sclerosing cholangitis is the most serious extraintestinal manifestation of ulcerative colitis and it does not resolve with colectomy.
  • Most common post operative complication of ileo anal pouch anastomosis in ulcerative colitis is Pouchitis.
  • Sulphonamide is used for the treatment of ulcerative colitis is Salazopyrin,Sulfasalazine.
  • Procedure of choice in ulcerative colitis with acute perforation is Total Colectomy with Ileostomy.
  • Best treatment for Remission of Acute ulcerative colitis is Prednisolone.
  • A 20 year old male presents with mucus and repeated gastrointestinal bleeding. Patient is positive for ANCA. The most likely diagnosis is Ulcerative Colitis.
  • A 25 year old male presents with a history of chronic diarrhea. Pathological examination reveals cryp. titis and crypt abscesses. The likely diagnosis is Ulcerative Colitis.
  • 5-amino salicylic acid is drug of choice for ulcerative colitis.
  • Methotrexate has not been shown to be effective for treating active ulcerative colitis or for maintaining remission.
  • Malignant potential is seen in both ulcerative colitis and Crohn’s disease, but ulcerative colitis is a more important risk factor than Crohn’s.
  • First radiological sign of ulcerative colitis is loss of Haustrations.
  • Pipe stem colon is seen in Ulcerative Colitis.
  • Agents that may be used for treatment of ulcerative colitis
  • 5-ASA
  • Glucocorticoids
  • Azathioprine and 6 mercaptopurine
  • Cyclosporine or TNF alpha therapy (Infliximab).
  • Tacrolimus 
Don’t Forget to Solve all the previous Year Question asked on Ulcerative Colitis

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support